• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑白质高信号:帕金森病无痴呆患者淡漠的标志物?

White matter hyperintensities: a marker for apathy in Parkinson's disease without dementia?

机构信息

Department of Neurology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 1665 Kong jiang Road, Shanghai, 200092, People's Republic of China.

出版信息

Ann Clin Transl Neurol. 2020 Sep;7(9):1692-1701. doi: 10.1002/acn3.51159. Epub 2020 Aug 28.

DOI:10.1002/acn3.51159
PMID:32857484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7480903/
Abstract

OBJECTIVE

The objective of this study was to assess the relationship between white matter hyperintensities (WMH) and the occurrence and progression of apathy in Parkinson's disease (PD).

METHODS

We recruited patients with PD who underwent baseline evaluation, which included apathy assessment and magnetic resonance imaging (MRI) head scans. After 2.5 years of follow-up, we re-evaluated patient apathy symptoms. The severity and location of WMH were assessed with fluid-attenuated inversion recovery (FLAIR) sequences using the Fazekas visual rating scale. Logistic regression and linear regression analyses of baseline WMH characteristics were conducted to explore the potential association between apathy and WMH.

RESULTS

A total of 141 PD patients were recruited. The apathy group had a higher proportion of male patients, advanced disease, and depression, which was coupled with a lower quality of life. Morever, higher WMH severity was significantly associated with apathy. Logistic regression analyses demonstrated that WMH severity was a risk factor for apathy. In addition, linear regression analysis also suggests that apathy severity is positively correlated with baseline WMH Fazekas scales (ϐ = 0.959, P < 0.001). Baseline WMH severity was also a risk factor for apathy progression.

INTERPRETATION

WMH is associated with apathy and could be a promising marker to predict apathy progression in PD.

摘要

目的

本研究旨在评估帕金森病(PD)患者脑白质高信号(WMH)与淡漠发生和进展之间的关系。

方法

我们招募了接受基线评估的 PD 患者,其中包括淡漠评估和磁共振成像(MRI)头部扫描。经过 2.5 年的随访后,我们重新评估了患者的淡漠症状。采用液体衰减反转恢复(FLAIR)序列,使用 Fazekas 视觉评分量表评估 WMH 的严重程度和位置。对基线 WMH 特征进行逻辑回归和线性回归分析,以探讨淡漠与 WMH 之间的潜在关联。

结果

共纳入 141 例 PD 患者。淡漠组男性患者比例较高,疾病进展程度较高,且抑郁症状较为明显,生活质量较低。此外,较高的 WMH 严重程度与淡漠显著相关。逻辑回归分析表明,WMH 严重程度是淡漠的危险因素。此外,线性回归分析还表明,淡漠严重程度与基线 WMH Fazekas 量表呈正相关(β=0.959,P<0.001)。基线 WMH 严重程度也是淡漠进展的危险因素。

结论

WMH 与淡漠有关,可能是预测 PD 患者淡漠进展的有前途的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f34/7480903/7ee244805a46/ACN3-7-1692-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f34/7480903/b477ee7ad0a7/ACN3-7-1692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f34/7480903/7ee244805a46/ACN3-7-1692-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f34/7480903/b477ee7ad0a7/ACN3-7-1692-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f34/7480903/7ee244805a46/ACN3-7-1692-g002.jpg

相似文献

1
White matter hyperintensities: a marker for apathy in Parkinson's disease without dementia?脑白质高信号:帕金森病无痴呆患者淡漠的标志物?
Ann Clin Transl Neurol. 2020 Sep;7(9):1692-1701. doi: 10.1002/acn3.51159. Epub 2020 Aug 28.
2
Microstructural Connectivity is More Related to Cognition than Conventional MRI in Parkinson's Disease.微观结构连通性与帕金森病的认知比常规 MRI 更相关。
J Parkinsons Dis. 2021;11(1):239-249. doi: 10.3233/JPD-202312.
3
White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson's disease.脑白质高信号与帕金森病患者左旋多巴诱导运动障碍的风险
Ann Clin Transl Neurol. 2020 Feb;7(2):229-238. doi: 10.1002/acn3.50991. Epub 2020 Feb 7.
4
Are Apathy and Depressive Symptoms Related to Vascular White Matter Hyperintensities in Severe Late Life Depression?严重老年期抑郁症患者的淡漠和抑郁症状与血管性脑白质高信号有关吗?
J Geriatr Psychiatry Neurol. 2021 Jan;34(1):21-28. doi: 10.1177/0891988720901783. Epub 2020 Feb 10.
5
White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease.脑白质高信号与帕金森病冻结步态的相关性研究
Parkinsonism Relat Disord. 2019 Sep;66:105-109. doi: 10.1016/j.parkreldis.2019.07.019. Epub 2019 Jul 15.
6
White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.脑白质高信号与早期帕金森病认知下降无关——DeNoPa 队列研究。
Parkinsonism Relat Disord. 2019 Dec;69:61-67. doi: 10.1016/j.parkreldis.2019.10.016. Epub 2019 Oct 19.
7
Hyperhomocysteinemia can predict the severity of white matter hyperintensities in elderly lacunar infarction patients.高同型半胱氨酸血症可预测老年腔隙性脑梗死患者脑白质高信号的严重程度。
Int J Neurosci. 2020 Mar;130(3):231-236. doi: 10.1080/00207454.2019.1667795. Epub 2019 Dec 20.
8
Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.白质高信号的进展及3年内新发腔隙性脑梗死的发生率:脑白质疏松症与残疾研究
Stroke. 2008 May;39(5):1414-20. doi: 10.1161/STROKEAHA.107.498535. Epub 2008 Mar 6.
9
White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.脑白质高信号在衰老和神经退行性疾病队列中的分布差异。
Neuroimage Clin. 2022;36:103204. doi: 10.1016/j.nicl.2022.103204. Epub 2022 Sep 16.
10
White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.MRI 上痴呆路易体病、痴呆帕金森病和阿尔茨海默病的脑白质高信号。
J Neurol Sci. 2018 Feb 15;385:99-104. doi: 10.1016/j.jns.2017.12.018. Epub 2017 Dec 19.

引用本文的文献

1
Behavioral disorders in Parkinson disease: current view.帕金森病中的行为障碍:当前观点
J Neural Transm (Vienna). 2025 Feb;132(2):169-201. doi: 10.1007/s00702-024-02846-3. Epub 2024 Oct 25.
2
Association of Plasma Lipids with White Matter Hyperintensities in Patients with Acute Ischemic Stroke.急性缺血性脑卒中患者血浆脂质与脑白质高信号的相关性
Int J Gen Med. 2023 Nov 21;16:5405-5415. doi: 10.2147/IJGM.S440655. eCollection 2023.
3
White matter hyperintensities associated with impulse control disorders in Parkinson's Disease.

本文引用的文献

1
An Investigation on the Clinical Features and Neurochemical Changes in Parkinson's Disease With Depression.帕金森病伴发抑郁的临床特征及神经化学变化的研究
Front Psychiatry. 2019 Jan 18;9:723. doi: 10.3389/fpsyt.2018.00723. eCollection 2018.
2
Clinical and demographic correlates of apathy in Parkinson's disease.帕金森病患者淡漠的临床和人口统计学相关性。
J Neurol. 2019 Feb;266(2):507-514. doi: 10.1007/s00415-018-9166-3. Epub 2019 Jan 2.
3
Fatigue in Parkinson's disease: A systematic review and meta-analysis.帕金森病疲劳:系统评价和荟萃分析。
与帕金森病冲动控制障碍相关的脑白质高信号。
Sci Rep. 2023 Jun 30;13(1):10594. doi: 10.1038/s41598-023-37054-8.
4
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases.脑白质高信号和皮质变薄与神经退行性疾病和脑血管病的神经精神症状有关。
Alzheimers Res Ther. 2023 Jun 20;15(1):114. doi: 10.1186/s13195-023-01257-y.
5
Apathy in Parkinson's Disease: Defining the Park Apathy Subtype.帕金森病中的淡漠:定义帕金森淡漠亚型
Brain Sci. 2022 Jul 14;12(7):923. doi: 10.3390/brainsci12070923.
6
Retinal microvascular changes in white matter hyperintensities investigated by swept source optical coherence tomography angiography.应用扫频源光相干断层扫描血管造影术研究脑白质高信号区的视网膜微血管变化。
BMC Ophthalmol. 2022 Feb 15;22(1):77. doi: 10.1186/s12886-021-02143-7.
Mov Disord. 2018 Nov;33(11):1712-1723. doi: 10.1002/mds.27461. Epub 2018 Sep 28.
4
White matter change with apathy and impulsivity in frontotemporal lobar degeneration syndromes.额颞叶变性综合征伴淡漠和冲动的白质改变。
Neurology. 2018 Mar 20;90(12):e1066-e1076. doi: 10.1212/WNL.0000000000005175. Epub 2018 Feb 16.
5
Apathy in drug-naïve patients with Parkinson's disease.帕金森病初治患者的淡漠。
Parkinsonism Relat Disord. 2017 Nov;44:28-32. doi: 10.1016/j.parkreldis.2017.08.008. Epub 2017 Aug 10.
6
Reduction of white matter integrity correlates with apathy in Parkinson's disease.帕金森病中白质完整性降低与冷漠相关。
Int J Neurosci. 2018 Jan;128(1):25-31. doi: 10.1080/00207454.2017.1347170. Epub 2017 Jul 18.
7
Differential relationships between apathy and depression with white matter microstructural changes and functional outcomes.冷漠与抑郁之间的差异关系以及白质微观结构变化和功能结果
Brain. 2015 Dec;138(Pt 12):3803-15. doi: 10.1093/brain/awv304. Epub 2015 Oct 21.
8
MDS clinical diagnostic criteria for Parkinson's disease.帕金森病的MDS临床诊断标准。
Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424.
9
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment.帕金森病中的淡漠:临床特征、神经基础、诊断和治疗。
Lancet Neurol. 2015 May;14(5):518-31. doi: 10.1016/S1474-4422(15)00019-8. Epub 2015 Apr 12.
10
Apathy in Parkinson's disease: A systematic review and meta-analysis.帕金森病中的淡漠:系统评价和荟萃分析。
Mov Disord. 2015 May;30(6):759-69. doi: 10.1002/mds.26208. Epub 2015 Mar 18.